Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

752
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
752
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

927
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
927

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Epidemiologically inferred reverse zoonosis and intra-household zoonotic re-exposure of <i>Mycobacterium tuberculosis</i> in a domestic dog: a one health alert and the diagnostic potential of hypercalcaemia.

Frontiers in veterinary science·2026
Same author

"That is why I trust": a qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia.

BMC health services research·2026
Same author

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Nature communications·2026
Same author

TBSure: an ESGMYC survey of pediatric TB management practices in high-income countries.

Frontiers in public health·2026
Same author

Future-proofing tuberculosis therapy: framework for concurrent drug and resistance testing development.

The Lancet. Infectious diseases·2026
Same author

Genomic characterization of the emerging multidrug-resistant <i>Klebsiella pneumoniae</i> ST6668 clone in northern Italy, 2020-2025.

Microbiology spectrum·2026

Related Experiment Video

Updated: Apr 16, 2026

Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

656

Defining the needs for next generation assays for tuberculosis.

Claudia M Denkinger1, Sandra V Kik2, Daniela Maria Cirillo3

  • 1FIND, Geneva, Switzerland Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

The Journal of Infectious Diseases
|March 14, 2015
PubMed
Summary

Novel diagnostics are crucial for tuberculosis control. This study outlines high-priority needs and target product profiles for advanced tuberculosis diagnostic tools to meet global health goals.

Keywords:
diagnosispoint-of-careprioritizationtarget product profilestuberculosis

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Amplicon Sequencing using the Long-Read Sequencing Technologies
08:57

Amplicon Sequencing using the Long-Read Sequencing Technologies

Published on: August 29, 2025

656
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.4K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

1.5K

Area of Science:

  • Global Health
  • Infectious Disease Diagnostics
  • Medical Technology

Background:

  • Tuberculosis (TB) control faces significant diagnostic challenges hindering progress towards global targets.
  • Existing diagnostic methods, like smear-microscopy, have limitations in accuracy and accessibility.
  • Novel diagnostics are essential for timely and effective TB management, especially in resource-limited settings.

Purpose of the Study:

  • To identify and prioritize critical diagnostic needs for accelerating the fight against tuberculosis.
  • To develop Target Product Profiles (TPPs) for high-priority TB diagnostic needs through a consensus process.
  • To guide the development and adoption of advanced TB diagnostics aligned with global health objectives.

Main Methods:

  • Stakeholder engagement to identify unmet needs in tuberculosis diagnostics.
  • Development of TPPs for prioritized diagnostic requirements.
  • A World Health Organization (WHO)-led consensus meeting to review and refine the TPPs.

Main Results:

  • Four high-priority diagnostic needs were identified: sputum-based replacement for smear-microscopy, non-sputum biomarker tests, low-cost triage tests, and rapid drug susceptibility tests.
  • TPPs were established for these critical diagnostic areas.
  • The TPPs aim to guide the diagnostics industry and TB community towards developing needed tools.

Conclusions:

  • Addressing these high-priority diagnostic needs is vital for achieving post-2015 global tuberculosis targets.
  • The developed TPPs provide a roadmap for innovation in TB diagnostics.
  • Collaboration between the TB community and the diagnostics industry, facilitated by these TPPs, is key to advancing TB control.